Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 56 | $12,096,913 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Mar 2024 20:42 | EXAS | EXACT SCIENCES CORP | ORVILLE JACOB A | General Manager, Screening | 01 Mar 2024 | Sale | 2,154 | 59.32 | 127,775 | D |
04 Mar 2024 20:42 | EXAS | EXACT SCIENCES CORP | LEVANGIE DANIEL J | Director | 01 Mar 2024 | Sale | 5,000 | 57.5 | 287,500 | D |
04 Mar 2024 20:41 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 01 Mar 2024 | Sale | 862 | 59.32 | 51,134 | D |
04 Mar 2024 20:40 | EXAS | EXACT SCIENCES CORP | ELLIOTT JEFFREY THOMAS | Chief Financial Officer | 01 Mar 2024 | Sale | 2,412 | 59.32 | 143,080 | D |
04 Mar 2024 20:39 | EXAS | EXACT SCIENCES CORP | DOYLE JAMES EDWARD | Director | 01 Mar 2024 | Sale | 2,000 | 57.5 | 115,000 | D |
04 Mar 2024 20:38 | EXAS | EXACT SCIENCES CORP | CUNNINGHAM EVERETT | Chief Commercial Officer | 01 Mar 2024 | Sale | 2,412 | 59.32 | 143,080 | D |
04 Mar 2024 20:38 | EXAS | EXACT SCIENCES CORP | CONROY KEVIN T | President and CEO | 01 Mar 2024 | Sale | 8,271 | 59.32 | 490,636 | D |
04 Mar 2024 20:37 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 01 Mar 2024 | Sale | 1,724 | 59.32 | 102,268 | D |
04 Mar 2024 20:36 | EXAS | EXACT SCIENCES CORP | BARANICK BRIAN | Gen. Mgr., Precision Oncology | 01 Mar 2024 | Sale | 2,323 | 59.32 | 137,800 | D |
28 Feb 2024 19:38 | EXAS | EXACT SCIENCES CORP | ORVILLE JACOB A | General Manager, Screening | 27 Feb 2024 | Sale | 1,879 | 56.89 | 106,896 | D |
28 Feb 2024 19:38 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 27 Feb 2024 | Sale | 784 | 56.89 | 44,602 | D |
28 Feb 2024 19:37 | EXAS | EXACT SCIENCES CORP | CUNNINGHAM EVERETT | Chief Commercial Officer | 27 Feb 2024 | Sale | 3,648 | 56.89 | 207,535 | D |
28 Feb 2024 19:36 | EXAS | EXACT SCIENCES CORP | ELLIOTT JEFFREY THOMAS | Chief Financial Officer | 27 Feb 2024 | Sale | 2,710 | 56.89 | 154,172 | D |
28 Feb 2024 19:35 | EXAS | EXACT SCIENCES CORP | CONROY KEVIN T | President and CEO | 27 Feb 2024 | Sale | 6,263 | 56.89 | 356,302 | D |
28 Feb 2024 19:35 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 27 Feb 2024 | Sale | 1,880 | 56.89 | 106,953 | D |
28 Feb 2024 19:34 | EXAS | EXACT SCIENCES CORP | BARANICK BRIAN | Gen. Mgr., Precision Oncology | 27 Feb 2024 | Sale | 2,027 | 56.89 | 115,316 | D |
26 Feb 2024 17:00 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 23 Feb 2024 | Sale | 1,021 | 59.72 | 60,974 | D |
23 Feb 2024 20:03 | EXAS | EXACT SCIENCES CORP | ORVILLE JACOB A | General Manager, Screening | 22 Feb 2024 | Sale | 1,013 | 59.78 | 60,557 | D |
23 Feb 2024 20:02 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 22 Feb 2024 | Sale | 291 | 59.78 | 17,396 | D |
23 Feb 2024 20:01 | EXAS | EXACT SCIENCES CORP | ELLIOTT JEFFREY THOMAS | Chief Financial Officer | 22 Feb 2024 | Sale | 1,351 | 59.78 | 80,763 | D |
23 Feb 2024 20:00 | EXAS | EXACT SCIENCES CORP | CUNNINGHAM EVERETT | Chief Commercial Officer | 22 Feb 2024 | Sale | 1,350 | 59.78 | 80,703 | D |
23 Feb 2024 19:59 | EXAS | EXACT SCIENCES CORP | COWARD D SCOTT | Director | 22 Feb 2024 | Sale | 663 | 59.78 | 39,634 | D |
23 Feb 2024 19:59 | EXAS | EXACT SCIENCES CORP | CONROY KEVIN T | President and CEO | 22 Feb 2024 | Sale | 11,565 | 59.78 | 691,356 | D |
23 Feb 2024 19:57 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 22 Feb 2024 | Sale | 1,013 | 59.78 | 60,557 | D |
23 Feb 2024 19:57 | EXAS | EXACT SCIENCES CORP | BARANICK BRIAN | Gen. Mgr., Precision Oncology | 22 Feb 2024 | Sale | 1,093 | 59.78 | 65,340 | D |
22 Feb 2024 19:40 | EXAS | EXACT SCIENCES CORP | ORVILLE JACOB A | General Manager, Screening | 21 Feb 2024 | Sale | 1,078 | 61.5 | 66,297 | D |
22 Feb 2024 19:39 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 21 Feb 2024 | Sale | 415 | 61.5 | 25,522 | D |
22 Feb 2024 19:38 | EXAS | EXACT SCIENCES CORP | ELLIOTT JEFFREY THOMAS | Chief Financial Officer | 21 Feb 2024 | Sale | 1,493 | 61.5 | 91,820 | D |
22 Feb 2024 19:38 | EXAS | EXACT SCIENCES CORP | COWARD D SCOTT | Director | 21 Feb 2024 | Sale | 706 | 61.5 | 43,419 | D |
22 Feb 2024 19:37 | EXAS | EXACT SCIENCES CORP | CONROY KEVIN T | President and CEO | 21 Feb 2024 | Sale | 4,975 | 61.5 | 305,962 | D |
22 Feb 2024 19:36 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 21 Feb 2024 | Sale | 1,079 | 61.5 | 66,358 | D |
22 Feb 2024 19:36 | EXAS | EXACT SCIENCES CORP | BARANICK BRIAN | Gen. Mgr., Precision Oncology | 21 Feb 2024 | Sale | 895 | 61.5 | 55,042 | D |
16 Feb 2024 18:26 | EXAS | EXACT SCIENCES CORP | ORVILLE JACOB A | General Manager, Screening | 15 Feb 2024 | Sale | 966 | 61.43 | 59,341 | D |
16 Feb 2024 18:25 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 15 Feb 2024 | Sale | 421 | 61.43 | 25,862 | D |
16 Feb 2024 18:24 | EXAS | EXACT SCIENCES CORP | ELLIOTT JEFFREY THOMAS | Chief Financial Officer | 15 Feb 2024 | Sale | 1,888 | 61.43 | 115,980 | D |
16 Feb 2024 18:23 | EXAS | EXACT SCIENCES CORP | COWARD D SCOTT | Director | 15 Feb 2024 | Sale | 1,376 | 61.43 | 84,528 | D |
16 Feb 2024 18:22 | EXAS | EXACT SCIENCES CORP | CONROY KEVIN T | President and CEO | 15 Feb 2024 | Sale | 14,791 | 61.43 | 908,611 | D |
16 Feb 2024 18:21 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 15 Feb 2024 | Sale | 965 | 61.43 | 59,280 | D |
04 Jan 2024 17:19 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 02 Jan 2024 | Sale | 2,000 | 73.5 | 147,000 | D |
04 Jan 2024 17:17 | EXAS | EXACT SCIENCES CORP | BARANICK BRIAN | Gen. Mgr., Precision Oncology | 02 Jan 2024 | Sale | 879 | 73.5 | 64,606 | D |
18 Dec 2023 19:49 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 14 Dec 2023 | Sale | 2,000 | 70 | 140,000 | D |
13 Oct 2023 19:59 | EXAS | EXACT SCIENCES CORP | CUNNINGHAM EVERETT | Chief Commercial Officer | 12 Oct 2023 | Sale | 13,007 | 66.49 | 864,835 | D |
06 Sep 2023 16:04 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 01 Sep 2023 | Sale | 4,500 | 84.36 | 379,620 | D |
23 Aug 2023 16:08 | EXAS | EXACT SCIENCES CORP | ELLIOTT JEFFREY THOMAS | Chief Financial Officer | 21 Aug 2023 | Sale | 30,210 | 82.92 | 2,505,013 | D |
08 Aug 2023 16:09 | EXAS | EXACT SCIENCES CORP | BARANICK BRIAN | Gen. Mgr., Precision Oncology | 07 Aug 2023 | Sale | 1,350 | 85.04 | 114,804 | D |
28 Jul 2023 16:06 | EXAS | EXACT SCIENCES CORP | DOYLE JAMES EDWARD | Director | 27 Jul 2023 | Sale | 2,000 | 97.42 | 194,840 | D |
21 Jul 2023 16:04 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 19 Jul 2023 | Sale | 1,300 | 100 | 130,000 | D |
12 Jun 2023 16:29 | EXAS | EXACT SCIENCES CORP | DOYLE JAMES EDWARD | Director | 09 Jun 2023 | Sale | 1,402 | 90.51 | 126,895 | D |
12 Jun 2023 16:17 | EXAS | EXACT SCIENCES CORP | ZANOTTI KATHERINE S | Director | 09 Jun 2023 | Sale | 3,027 | 90.51 | 273,974 | D |
12 Jun 2023 16:14 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 08 Jun 2023 | Sale | 1,300 | 90 | 117,000 | D |
31 May 2023 16:13 | EXAS | EXACT SCIENCES CORP | DOYLE JAMES EDWARD | Director | 26 May 2023 | Sale | 2,000 | 80.62 | 161,240 | D |
12 May 2023 16:11 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 10 May 2023 | Sale | 6,087 | 80 | 486,960 | D |
12 May 2023 16:09 | EXAS | EXACT SCIENCES CORP | ORVILLE JACOB A | General Manager, Screening | 10 May 2023 | Sale | 5,000 | 80 | 400,000 | D |
12 May 2023 16:07 | EXAS | EXACT SCIENCES CORP | HERRIOTT JAMES | General Counsel | 10 May 2023 | Sale | 1,300 | 79.85 | 103,805 | D |
03 May 2023 16:04 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 01 May 2023 | Sale | 1,000 | 63.78 | 63,780 | D |
05 Apr 2023 16:10 | EXAS | EXACT SCIENCES CORP | CONDELLA SARAH | EVP, Human Resources | 03 Apr 2023 | Sale | 1,000 | 67.19 | 67,190 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)